Prognostic value of growth differentiation factor 15 in older patients undergoing emergency abdominal surgery: a prospective observational study at a tertiary hospital

Background Emergency abdominal surgery in frail older patients carries a high risk of mortality and cardiovascular complications. Growth differentiation factor 15 (GDF-15) is a strong prognostic marker across different patient populations and may improve perioperative risk stratification. We assessed associations between preoperative GDF-15 concentrations and postoperative outcomes in older patients undergoing emergency abdominal surgery. Methods This preplanned secondary biomarker substudy of the ProPEL cohort included 142 patients aged ≥75 yr undergoing emergency abdominal surgery between January 2020 and April 2021. The primary endpoint was 30-day all-cause mortality. Secondary endpoints were 90-day mortality and 30-day mortality or major adverse cardiac events (MACEs). Intraoperative blood transfusion was added as a post hoc exploratory analysis. Results Overall, 30-day all-cause mortality was 12% (17/142). Mortality was 31% (11/36) in the highest GDF-15 quartile compared with 6% (2/35 or 2/36) in each of the lower quartiles. Each doubling of GDF-15 was associated with increased 30-day mortality (hazard ratio: 1.75, 95% confidence interval: 1.15–2.66, P =0.009) independent of age, sex, and Clinical Frailty Scale, and in a model adjusted for high-sensitivity cardiac troponin T hazard ratio 1.65 (1.03–2.65), P=0.037. GDF-15 predicted 30-day death or MACE, adjusted for age, sex, and Clinical Frailty Scale, but not after adjusting for high-sensitivity cardiac troponin T. Associations with 90-day mortality were attenuated after adjustment. A doubling of GDF-15 concentrations was associated with an adjusted odds ratio of 1.90 (95% confidence interval 1.29–2.78, P =0.001) for intraoperative blood transfusion. Conclusions GDF-15 was associated with 30-day mortality and the need for blood transfusion in older adults undergoing acute abdominal surgery.

Authors

Institutions

Publication Details

Journal
BJA Open
Published
2026-11-18
DOI
https://doi.org/10.1016/j.bjao.2026.100894
Primary Topic
GDF15 and Related Biomarkers
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Prognostic value of growth differentiation factor 15 in older patients undergoing emergency abdominal surgery: a prospective observational study at a tertiary hospital

Kristin Moberg Aakre, Gard M. S. Myrmel, Erik Wilhelm Vinnes, Ib Jammer et al.
BJA Open
GDF15 and Related Biomarkers
article

Prognostic value of growth differentiation factor 15 in older patients undergoing emergency abdominal surgery: a prospective observational study at a tertiary hospital

Kristin Moberg Aakre, Gard M. S. Myrmel, Erik Wilhelm Vinnes, Ib Jammer, Elin Kismul Aakre, Jørn Vegard Sagen
article en

Abstract

Background Emergency abdominal surgery in frail older patients carries a high risk of mortality and cardiovascular complications. Growth differentiation factor 15 (GDF-15) is a strong prognostic marker across different patient populations and may improve perioperative risk stratification. We assessed associations between preoperative GDF-15 concentrations and postoperative outcomes in older patients undergoing emergency abdominal surgery. Methods This preplanned secondary biomarker substudy of the ProPEL cohort included 142 patients aged ≥75 yr undergoing emergency abdominal surgery between January 2020 and April 2021. The primary endpoint was 30-day all-cause mortality. Secondary endpoints were 90-day mortality and 30-day mortality or major adverse cardiac events (MACEs). Intraoperative blood transfusion was added as a post hoc exploratory analysis. Results Overall, 30-day all-cause mortality was 12% (17/142). Mortality was 31% (11/36) in the highest GDF-15 quartile compared with 6% (2/35 or 2/36) in each of the lower quartiles. Each doubling of GDF-15 was associated with increased 30-day mortality (hazard ratio: 1.75, 95% confidence interval: 1.15–2.66, P =0.009) independent of age, sex, and Clinical Frailty Scale, and in a model adjusted for high-sensitivity cardiac troponin T hazard ratio 1.65 (1.03–2.65), P=0.037. GDF-15 predicted 30-day death or MACE, adjusted for age, sex, and Clinical Frailty Scale, but not after adjusting for high-sensitivity cardiac troponin T. Associations with 90-day mortality were attenuated after adjustment. A doubling of GDF-15 concentrations was associated with an adjusted odds ratio of 1.90 (95% confidence interval 1.29–2.78, P =0.001) for intraoperative blood transfusion. Conclusions GDF-15 was associated with 30-day mortality and the need for blood transfusion in older adults undergoing acute abdominal surgery.

BJA OpenVol. 20
University of Oslo (NO), Akershus University Hospital (NO), Haukeland University Hospital (NO), University of Bergen (NO)
Helse Vest, Haukeland Universitetssjukehus, Roche Diagnostics
Good health and well-being
GDF15 and Related Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon